Clinical course in Parkinson's disease with elevated homocysteine
Authors:
- Padraig E. O'SuilleabhainPOPadraig E. O'Suilleabhain
- Robert OberleRORobert Oberle
- Cristina BartisCBCristina Bartis
- Richard B. DeweyRDRichard B. Dewey
- Teodoro BottiglieriTBTeodoro Bottiglieri
- Ramon Diaz-ArrastiaRDRamon Diaz-Arrastia
- 31 March 2006
- journal article
- Published by Elsevier in Parkinsonism & Related Disorders
- Vol. 12 (2) , 103-107
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Modest increase in plasma homocysteine follows levodopa initiation in Parkinson's diseaseMovement Disorders, 2004
- Elevated Plasma Homocysteine Level in Patients With Parkinson DiseaseArchives of Neurology, 2004
- Levodopa-induced hyperhomocysteinaemia in Parkinson's diseaseActa Neurologica Scandinavica, 2003
- Vitamin B12, Folate, and Homocysteine in Depression: The Rotterdam StudyAmerican Journal of Psychiatry, 2002
- Plasma Homocysteine as a Risk Factor for Dementia and Alzheimer's DiseaseNew England Journal of Medicine, 2002
- Risk of dementia in Parkinson’s diseaseNeurology, 2001
- Hopkins Verbal Learning Test – Revised: Normative Data and Analysis of Inter-Form and Test-Retest ReliabilityThe Clinical Neuropsychologist, 1998
- Rapid high-performance liquid chromatographic assay for total homocysteine levels in human serumJournal of Chromatography B: Biomedical Sciences and Applications, 1991
- “Mini-mental state”Journal of Psychiatric Research, 1975